Immunomodulatory potential of anticancer therapy composed of methotrexate nanoconjugate and dendritic cell ‑based vaccines in murine colon carcinoma.

In conclusion, due to its immunomodulatory properties, the HES‑MTX nanoconjugate could become a potent anticancer agent used in both chemo‑ and chemoimmunotherapeutic treatment schemes. PMID: 33432365 [PubMed - as supplied by publisher]
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research